Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis
Chiara Cremolini, Carlotta Antoniotti, Filippo Pietrantonio, Rosa Berenato, Marco Tampellini, Chiara Baratelli, Lisa Salvatore, Federica Marmorino, Beatrice Borelli, Federico Nichetti, Paolo Bironzo, Cristina Sonetto, Maria Di Bartolomeo, Filippo de Braud, Fotios Loupakis, Alfredo Falcone, Massimo Di Maio
Cancer Res Treat. 2017;49(3):834-845.   Published online 2016 Nov 15     DOI: https://doi.org/10.4143/crt.2016.249
Citations to this article as recorded by Crossref logo
Surrogate Endpoints in Oncology: Overview of Systematic Reviews and Their Use for Health Decision Making in Mexico
Yesenia Ortiz, Christian J. Fareli, Veronica Gallegos, Esteban Hernández
Value in Health Regional Issues.2021; 26: 75.     CrossRef
Primary and metastatic peritoneal surface malignancies
Delia Cortés-Guiral, Martin Hübner, Mohammad Alyami, Aditi Bhatt, Wim Ceelen, Olivier Glehen, Florian Lordick, Robert Ramsay, Olivia Sgarbura, Kurt Van Der Speeten, Kiran K. Turaga, Manish Chand
Nature Reviews Disease Primers.2021;[Epub]     CrossRef
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson, Stephen Palmer
Health Technology Assessment.2021; 25(76): 1.     CrossRef
Combining Correlated Outcomes and Surrogate Endpoints in a Network Meta-Analysis of Colorectal Cancer Treatments
Tung Hoang, Jeongseon Kim
Cancers.2020; 12(9): 2663.     CrossRef
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer
Katy Cooper, Paul Tappenden, Anna Cantrell, Kate Ennis
British Journal of Cancer.2020; 123(11): 1686.     CrossRef
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer
L. Mineur, E. François, C. Plassot, J. M. Phelip, L. Miglianico, L. M. Dourthe, N. Bonichon, L. Moreau, R. Guimbaud, D. Smith, E. Achille, R. Hervé, J. M. Bons, S. Remy, R. Faroux, A. L. Villing, A. Mahamat, I. Rabbia, P. Soulié, I. Baumgaertner, N. Mathé
PLOS ONE.2020; 15(12): e0243997.     CrossRef
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology
Alyson Haslam, Spencer P. Hey, Jennifer Gill, Vinay Prasad
European Journal of Cancer.2019; 106: 196.     CrossRef
Mesure de la réponse radiologique scannographique des cancers colorectaux métastatiques : état des lieux et perspectives
Achille Fabre, Nicolas Badet, Paul Calame, Eric Delabrousse, Mylène Wespiser, Celia Turco, Christophe Borg, Marine Jary
Bulletin du Cancer.2019; 106(11): 1029.     CrossRef
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
Marcin Waligora, Malgorzata M. Bala, Magdalena Koperny, Mateusz T. Wasylewski, Karolina Strzebonska, Rafał R. Jaeschke, Agnieszka Wozniak, Jan Piasecki, Agnieszka Sliwka, Jerzy W. Mitus, Maciej Polak, Dominika Nowis, Dean Fergusson, Jonathan Kimmelman, Ma
PLOS Medicine.2018; 15(2): e1002505.     CrossRef